| Product Code: ETC6078019 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Andorra Neurovascular Accessory Devices Market Overview |
3.1 Andorra Country Macro Economic Indicators |
3.2 Andorra Neurovascular Accessory Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Andorra Neurovascular Accessory Devices Market - Industry Life Cycle |
3.4 Andorra Neurovascular Accessory Devices Market - Porter's Five Forces |
3.5 Andorra Neurovascular Accessory Devices Market Revenues & Volume Share, By Disease Pathology, 2021 & 2031F |
3.6 Andorra Neurovascular Accessory Devices Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.7 Andorra Neurovascular Accessory Devices Market Revenues & Volume Share, By Therapeutic Applications, 2021 & 2031F |
3.8 Andorra Neurovascular Accessory Devices Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Andorra Neurovascular Accessory Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurovascular disorders in Andorra |
4.2.2 Technological advancements in neurovascular accessory devices |
4.2.3 Growing awareness about treatment options for neurovascular conditions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for medical devices in Andorra |
4.3.2 Limited healthcare infrastructure in the country |
4.3.3 High cost associated with neurovascular accessory devices |
5 Andorra Neurovascular Accessory Devices Market Trends |
6 Andorra Neurovascular Accessory Devices Market, By Types |
6.1 Andorra Neurovascular Accessory Devices Market, By Disease Pathology |
6.1.1 Overview and Analysis |
6.1.2 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Disease Pathology, 2021- 2031F |
6.1.3 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Aneurysm, 2021- 2031F |
6.1.4 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Arteriovenous Malformation (AVM), 2021- 2031F |
6.1.5 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Ischemic Stroke, 2021- 2031F |
6.1.6 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Stenosis, 2021- 2031F |
6.1.7 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Andorra Neurovascular Accessory Devices Market, By Process |
6.2.1 Overview and Analysis |
6.2.2 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Neurothrombectomy, 2021- 2031F |
6.2.3 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Cerebral Angiography, 2021- 2031F |
6.2.4 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Carotid Endarterectomy, 2021- 2031F |
6.2.5 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Stenting, 2021- 2031F |
6.2.6 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Microsurgical Clipping, 2021- 2031F |
6.2.7 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Coiling, 2021- 2031F |
6.3 Andorra Neurovascular Accessory Devices Market, By Therapeutic Applications |
6.3.1 Overview and Analysis |
6.3.2 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Brain Aneurysm, 2021- 2031F |
6.3.3 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Stenosis, 2021- 2031F |
6.3.4 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Ischemic Strokes, 2021- 2031F |
6.4 Andorra Neurovascular Accessory Devices Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.4.4 Andorra Neurovascular Accessory Devices Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Andorra Neurovascular Accessory Devices Market Import-Export Trade Statistics |
7.1 Andorra Neurovascular Accessory Devices Market Export to Major Countries |
7.2 Andorra Neurovascular Accessory Devices Market Imports from Major Countries |
8 Andorra Neurovascular Accessory Devices Market Key Performance Indicators |
8.1 Number of neurovascular procedures performed in Andorra |
8.2 Adoption rate of new neurovascular accessory devices in the market |
8.3 Patient outcomes and satisfaction rates post neurovascular procedures |
9 Andorra Neurovascular Accessory Devices Market - Opportunity Assessment |
9.1 Andorra Neurovascular Accessory Devices Market Opportunity Assessment, By Disease Pathology, 2021 & 2031F |
9.2 Andorra Neurovascular Accessory Devices Market Opportunity Assessment, By Process, 2021 & 2031F |
9.3 Andorra Neurovascular Accessory Devices Market Opportunity Assessment, By Therapeutic Applications, 2021 & 2031F |
9.4 Andorra Neurovascular Accessory Devices Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Andorra Neurovascular Accessory Devices Market - Competitive Landscape |
10.1 Andorra Neurovascular Accessory Devices Market Revenue Share, By Companies, 2024 |
10.2 Andorra Neurovascular Accessory Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here